Who makes E7449 plus carboplatin and paclitaxel?

E7449 plus carboplatin and paclitaxel is developed by Eisai Limited.

What development phase is E7449 plus carboplatin and paclitaxel in?

E7449 plus carboplatin and paclitaxel is in Phase 1.

Last reviewed 2026-05-14 · How we verify

E7449 plus carboplatin and paclitaxel

Eisai Limited · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	E7449 plus carboplatin and paclitaxel
Sponsor	Eisai Limited
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

E7449 plus carboplatin and paclitaxel CI brief — competitive landscape report
E7449 plus carboplatin and paclitaxel updates RSS · CI watch RSS
Eisai Limited portfolio CI